Closed-loop generative selection has become a workhorse of computational drug discovery: a learned generative model proposes candidate molecules, a fitness oracle scores them, the best are kept, and the model is retrained on this elite set before the next round. Despite its wide use, the method has lacked a rigorous convergence theory, largely because retraining the model each round breaks the Markov property on which classical evolutionary-algorithm analysis relies. We develop a self-contained theory of convergence and expected running time for this class of algorithms. By recovering a Markov structure on an enlarged state space, we show that elitism makes the search absorbing, and we prove almost-sure convergence together with a runtime bound that decomposes the search into the time spent escaping each fitness level. We then analyse the role of the model’s memory—how much of the past it is trained on. When learning improves steadily with more data, deeper memory never hurts; when it does not, an exit-time analysis pinpoints the optimal memory depth and shows that excess memory can actually slow convergence. The theory extends to multi-objective search and to noisy oracles: we quantify how many repeated evaluations certify progress under light-tailed noise, and how robust estimators restore guarantees under heavy tails. Recast in terms of oracle evaluations - the true bottleneck in drug design - the analysis yields a concrete, evaluation-minimal strategy. Areproducible study confirms the predictions, including the surprising cost of excess memory. We close with three open problems.

生成讲解博客的中文版本

生成AI智能校验的中文版本